Suppr超能文献

中度主动脉瓣狭窄的自然病史观察。

Natural history observations in moderate aortic stenosis.

机构信息

Roger L. and Lynn C. Headrick Chair, Valve Science Center, Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN, 55407, USA.

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.

出版信息

BMC Cardiovasc Disord. 2021 Feb 19;21(1):108. doi: 10.1186/s12872-021-01901-1.

Abstract

BACKGROUND

The natural history of patients with moderate aortic stenosis (AS) is poorly understood. We aimed to determine the long-term outcomes of patients with moderate AS.

METHODS

We examined patients with moderate AS defined by echocardiography in our healthcare system, and performed survival analyses for occurrence of death, heart failure (HF) hospitalization, and progression of AS, with accounting for symptoms, left ventricular dysfunction, and comorbidities.

RESULTS

We examined 729 patients with moderate AS (median age, 76 years; 59.9 % men) with a median follow-up of 5.0 years (interquartile range: 2.0 to 8.1 years). The 5-year overall survival was 52.3 % (95 % confidence interval [CI]: 48.6 % to 56.0 %) and survival free of death or HF hospitalization was 43.2 % (95 % CI: 39.5 % to 46.9 %). Worse New York Heart Association (NYHA) functional class was associated with poor long-term survival, with mortality rates ranging from 7.9 % (95 % CI: 6.6-9.2 %) to 25.2 % (95 % CI: 20.2-30.3 %) per year. Among patients with minimal or no symptoms, no futility markers, and preserved left ventricular function, 5-year overall survival was 71.9 % (95 % CI: 66.4-77.4 %) and survival free of death or HF hospitalization was 61.4 % (95 % CI: 55.5-67.3 %). Risk factors associated with adverse events were age, NYHA class, low ejection fraction and high aortic valve velocity (all p < 0.05).

CONCLUSIONS

Patients with moderate AS are at significant risk of death. Our findings highlight the need for more study into appropriate therapeutic interventions to improve the prognosis of these patients.

摘要

背景

中度主动脉瓣狭窄(AS)患者的自然病程尚不清楚。我们旨在确定中度 AS 患者的长期预后。

方法

我们检查了我们医疗系统中通过超声心动图诊断为中度 AS 的患者,并对死亡、心力衰竭(HF)住院和 AS 进展的发生进行了生存分析,同时考虑了症状、左心室功能障碍和合并症。

结果

我们检查了 729 名中度 AS 患者(中位年龄 76 岁;59.9%为男性),中位随访时间为 5.0 年(四分位距:2.0 至 8.1 年)。5 年总生存率为 52.3%(95%置信区间:48.6%至 56.0%),无死亡或 HF 住院生存率为 43.2%(95%置信区间:39.5%至 46.9%)。更差的纽约心脏协会(NYHA)功能分级与长期生存不良相关,死亡率范围为每年 7.9%(95%置信区间:6.6-9.2%)至 25.2%(95%置信区间:20.2-30.3%)。在无或仅有轻微症状、无无效标志物和保留左心室功能的患者中,5 年总生存率为 71.9%(95%置信区间:66.4-77.4%),无死亡或 HF 住院生存率为 61.4%(95%置信区间:55.5-67.3%)。与不良事件相关的危险因素是年龄、NYHA 分级、低射血分数和高主动脉瓣速度(均 p<0.05)。

结论

中度 AS 患者死亡风险显著增加。我们的研究结果强调需要进一步研究适当的治疗干预措施,以改善这些患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40a/7893941/03580d0f104f/12872_2021_1901_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验